Skip to main content

Table 2 The hazard ratios and P-values for the associations between DNA methylation of seven key CpG loci and four clinical prognostic endpoints of GC patients in TCGA

From: DNA methylation signatures associated with prognosis of gastric cancer

CpG sites

Genomic positions

Gene names

Genomic groups (CpG contents)

Training set

Validation set

Pooled set

HR (95% CI)a

P-value

FDR

HR (95% CI)a

P-value

HR (95% CI)a

P-value

OS

 cg11348188

chr2–222,655,366

EPHA4, PAX3

Intergenic (open sea)

1.69 (1.32–2.18)

3.84 × 10−5

0.012

1.33 (1.05–1.68)

0.017

1.46 (1.23–1.72)

1.44 × 10− 5

 cg25117092a

chr3–150,948,274

MED12L

Body (open sea)

1.67 (1.29–2.16)

1.03 × 10−4

0.017

1.28 (1.01–1.62)

0.037

1.42 (1.20–1.69)

4.70 × 10− 5

 cg05275153b

chr4–3,431,837

RGS12

Body (open sea)

0.79 (0.68–0.91)

9.97 × 10− 4

0.042

0.69 (0.56–0.86)

8.99 × 10− 4

0.74 (0.65–0.84)

3.02 × 10−6

 cg11671115

chr10–87,336,486

FAM190B, GRID1

Intergenic (open sea)

1.58 (1.22–2.04)

4.85 × 10− 4

0.032

1.36 (1.08–1.71)

0.010

1.42 (1.20–1.67)

3.52 × 10−5

 cg14719951c

chr18–28,622,474

DSC3

Body (island)

0.69 (0.55–0.87)

1.33 × 10−3

0.048

0.74 (0.58–0.93)

0.010

0.72 (0.61–0.84)

4.22 × 10−5

 cg10399824d

chr10–121,048,354

GRK5

Body (open sea)

0.61 (0.50–0.75)

3.67 × 10−6

0.005

0.65 (0.53–0.80)

4.01 × 10−5

0.65 (0.56–0.74)

7.00 × 10−10

 cg24406668e

chr20–44,639,431

MMP9

Body (island)

0.59 (0.46–0.76)

2.88 × 10−5

0.011

0.78 (0.62–0.99)

0.037

0.70 (0.59–0.82)

2.29 × 10−5

DSS

 cg11348188

chr2–222,655,366

EPHA4, PAX3

Intergenic (open sea)

1.54 (1.16–2.06)

3.10 × 10−3

0.028

2.05 (1.45–2.90)

4.41 × 10−5

1.73 (1.39–2.15)

9.42 × 10−7

 cg25117092a

chr3–150,948,274

MED12L

Body (open sea)

1.49 (1.10–2.00)

8.95 × 10−3

0.043

1.75 (1.27–2.40)

5.66 × 10−4

1.60 (1.29–1.98)

2.17 × 10−5

 cg05275153b

chr4–3,431,837

RGS12

Body (open sea)

0.67 (0.55–0.82)

1.04 × 10−4

0.005

0.70 (0.53–0.91)

0.009

0.69 (0.59–0.80)

1.32 × 10−6

 cg11671115

chr10–87,336,486

FAM190B, GRID1

Intergenic (open sea)

1.59 (1.19–2.12)

1.79 × 10−3

0.020

1.71 (1.26–2.31)

5.65 × 10−4

1.65 (1.34–2.04)

2.43 × 10−6

 cg14719951c

chr18–28,622,474

DSC3

Body (island)

0.64 (0.49–0.85)

1.62 × 10−3

0.020

0.65 (0.49–0.88)

0.005

0.65 (0.53–0.79)

2.16 × 10−5

 cg10399824d

chr10–121,048,354

GRK5

Body (open sea)

0.54 (0.42–0.69)

9.20 × 10−7

1.31 × 10−4

0.57 (0.44–0.73)

7.12 × 10−6

0.57 (0.48–0.67)

1.65 × 10−11

 cg24406668e

chr20–44,639,431

MMP9

Body (island)

0.71 (0.53–0.93)

1.46 × 10−2

0.050

0.54 (0.39–0.74)

1.49 × 10− 4

0.62 (0.50–0.76)

6.56 × 10−6

PFI

 cg11348188

chr2–222,655,366

EPHA4, PAX3

Intergenic (open sea)

1.65 (1.27–2.13)

1.53 × 10−4

0.021

1.53 (1.17–1.99)

0.002

1.58 (1.32–1.89)

7.00 × 10−7

 cg25117092a

chr3–150,948,274

MED12L

Body (open sea)

1.47 (1.16–1.86)

1.53 × 10−3

0.049

1.48 (1.12–1.94)

0.005

1.49 (1.25–1.79)

1.07 × 10−5

 cg05275153b

chr4–3,431,837

RGS12

Body (open sea)

0.71 (0.59–0.87)

6.84 × 10−4

0.043

0.54 (0.41–0.72)

2.11 × 10−5

0.70 (0.61–0.80)

2.17 × 10−7

 cg11671115

chr10–87,336,486

FAM190B, GRID1

Intergenic (open sea)

1.57 (1.24–1.99)

1.86 × 10−4

0.021

1.40 (1.08–1.83)

0.011

1.51 (1.27–1.80)

3.12 × 10−6

 cg14719951c

chr18–28,622,474

DSC3

Body (island)

0.69 (0.55–0.87)

1.52 × 10−3

0.049

0.77 (0.60–0.99)

0.043

0.73 (0.62–0.86)

2.48 × 10−4

 cg10399824d

chr10–121,048,354

GRK5

Body (open sea)

0.57 (0.46–0.7)

1.26 × 10−7

5.62 × 10−5

0.75 (0.59–0.96)

0.020

0.63 (0.54–0.74)

5.10 × 10−9

 cg24406668e

chr20–44,639,431

MMP9

Body (island)

0.68 (0.54–0.86)

1.24 × 10−3

0.049

0.68 (0.52–0.90)

0.007

0.69 (0.58–0.83)

4.74 × 10−5

DFI

 cg11348188

chr2–222,655,366

EPHA4, PAX3

Intergenic (open sea)

–

–

–

–

–

1.51 (1.12–2.05)

0.007

 cg25117092a

chr3–150,948,274

MED12L

Body (open sea)

–

–

–

–

–

1.75 (1.27–2.42)

0.001

 cg05275153b

chr4–3,431,837

RGS12

Body (open sea)

–

–

–

–

–

0.77 (0.63–0.94)

0.012

 cg11671115

chr10–87,336,486

FAM190B, GRID1

Intergenic (open sea)

–

–

–

–

–

1.59 (1.18–2.14)

0.002

 cg14719951c

chr18–28,622,474

DSC3

Body (island)

–

–

–

–

–

0.74 (0.56–0.99)

0.042

 cg103998244

chr10–121,048,354

GRK5

Body (open sea)

–

–

–

–

–

0.78 (0.60–1.01)

0.059

 cg244066685

chr20–44,639,431

MMP9

Body (island)

–

–

–

–

–

0.77 (0.57–1.04)

0.089

  1. Abbreviations: GC gastric cancer, OS overall survival, DSS disease-specific survival, DFI disease-free interval, PFI progression-free interval, HRs hazard ratios, CI confidence interval, FDR false discovery rate
  2. aCox regression analyses adjusting for age at initial pathologic diagnosis (continuous) and gender (male, female).
  3. bDistance to the closest TSS for cg25117092 (MED12L) is 39,570 bp
  4. cDistance to the closest TSS for cg05275153 (RGS12) is 2021 bp
  5. dDistance to thee closest TSS for cg14719951 (DSC3) is 308 bp
  6. eDistance to the closest TSS for cg10399824 is (GRK5) 81271 bp
  7. fDistance to the closest TSS for cg24406668 is (MMP9) 1884 bp